These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
509 related items for PubMed ID: 26321494
1. Pancreatic neuroendocrine tumors containing areas of iso- or hypoattenuation in dynamic contrast-enhanced computed tomography: Spectrum of imaging findings and pathological grading. Hyodo R, Suzuki K, Ogawa H, Komada T, Naganawa S. Eur J Radiol; 2015 Nov; 84(11):2103-9. PubMed ID: 26321494 [Abstract] [Full Text] [Related]
2. Prediction of lymph node metastasis in pancreatic neuroendocrine tumors by contrast enhancement characteristics. Mizumoto T, Toyama H, Terai S, Mukubou H, Yamashita H, Shirakawa S, Nanno Y, Sofue K, Kido M, Ajiki T, Fukumoto T. Pancreatology; 2017 Nov; 17(6):956-961. PubMed ID: 28964660 [Abstract] [Full Text] [Related]
3. Pancreatic neuroendocrine tumors: Correlation between the contrast-enhanced computed tomography features and the pathological tumor grade. Takumi K, Fukukura Y, Higashi M, Ideue J, Umanodan T, Hakamada H, Kanetsuki I, Yoshiura T. Eur J Radiol; 2015 Aug; 84(8):1436-1443. PubMed ID: 26022520 [Abstract] [Full Text] [Related]
4. Nonhypervascular pancreatic neuroendocrine tumors: Spectrum of MDCT imaging findings and differentiation from pancreatic ductal adenocarcinoma. Karmazanovsky G, Belousova E, Schima W, Glotov A, Kalinin D, Kriger A. Eur J Radiol; 2019 Jan; 110():66-73. PubMed ID: 30599875 [Abstract] [Full Text] [Related]
5. Textural analysis on contrast-enhanced CT in pancreatic neuroendocrine neoplasms: association with WHO grade. Guo C, Zhuge X, Wang Z, Wang Q, Sun K, Feng Z, Chen X. Abdom Radiol (NY); 2019 Feb; 44(2):576-585. PubMed ID: 30182253 [Abstract] [Full Text] [Related]
13. [CT and MRI findings of primary hepatic neuroendocrine neoplasm]. Li JK, Wang M, Yuan J, Song ZG. Zhonghua Zhong Liu Za Zhi; 2017 Aug 23; 39(8):600-606. PubMed ID: 28835083 [Abstract] [Full Text] [Related]
15. Contrast-enhanced MDCT in patients with pancreatic neuroendocrine tumours: correlation with histological findings and diagnostic performance in differentiation between tumour grades. Belousova E, Karmazanovsky G, Kriger A, Kalinin D, Mannelli L, Glotov A, Karelskaya N, Paklina O, Kaldarov A. Clin Radiol; 2017 Feb 23; 72(2):150-158. PubMed ID: 27890421 [Abstract] [Full Text] [Related]
17. Comparison between neuroendocrine carcinomas and well-differentiated neuroendocrine tumors of the pancreas using dynamic enhanced CT. Park HJ, Kim HJ, Kim KW, Kim SY, Choi SH, You MW, Hwang HS, Hong SM. Eur Radiol; 2020 Sep 23; 30(9):4772-4782. PubMed ID: 32346794 [Abstract] [Full Text] [Related]
18. Contrast-Enhanced Ultrasonography Findings Correlate with Pathologic Grades of Pancreatic Neuroendocrine Tumors. Huang J, Chen J, Xu M, Zheng Y, Lin M, Huang G, Xie X, Xie X. Ultrasound Med Biol; 2021 Aug 23; 47(8):2097-2106. PubMed ID: 33934943 [Abstract] [Full Text] [Related]